Granite reaps $80M Texas farm-to-market highway job
Farm to Market Road 548 near Dallas, part of the state’s historic network of rural byways connecting agricultural centers to cities, will get a concrete makeover.
Apogee (NASDAQ:APOG) Exceeds Q1 Expectations, Full-Year Sales Guidance is Optimistic
Architectural products company Apogee (NASDAQ:APOG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 4.5% year on year to $345.7 million. The company’s full-year revenue guidance of $1.4 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $0.89 per share was 2.3% above analysts’ consensus estimates.
Russia's Finance Ministry to Offer Crypto Trading to 'Highly-Qualified' Investors: Report
The exchange will "legalize crypto assets and bring cryto operations out of the shadows," Finance Minister Anton Siluanov said
S&P 500, Nasdaq inch higher on tech boost, earnings weigh on Dow
Wall Street's main indexes were mixed on Thursday, with the S&P 500 and the Nasdaq rising, as investors assessed a slew of mixed corporate results and monitored developments in U.S.-China trade war. The White House on Wednesday indicated that it was open to reducing sweeping tariffs on China, and President Donald Trump stepped back from his attacks on Federal Reserve Chairman Jerome Powell, sending stock indexes higher. But the optimism faded when Treasury Secretary Scott Bessent said a move to reduce levies would not come unilaterally, while China said in response that the U.S. should lift all unilateral tariff measures against China if it "truly" wanted to solve the trade issue.
LKQ (NASDAQ:LKQ) Misses Q1 Sales Targets, Stock Drops
Automotive parts company LKQ (NASDAQ:LKQ) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.5% year on year to $3.46 billion. Its non-GAAP profit of $0.79 per share was 1.5% above analysts’ consensus estimates.
Dow warns of earnings pressure due to tariff uncertainty
(Reuters) -Chemicals firm Dow Inc said on Thursday that it expects extended pressure on earnings as uncertainty from U.S. President Donald Trump's erratic trade policies adds to macroeconomic volatility. Along with other chemicals firms, Dow has been struggling with higher feedstock and energy costs as well as weak demand and prices for its products, especially in markets such as Europe. "Our industry is in one of the most protracted downcycles in decades," CEO Jim Fitterling said in a post-earnings call.
Fed report uses the word ‘uncertainty’ 80 times and global stock markets don’t know where to go
U.S. stock indexes closed up yesterday following news that the Trump administration would compromise on some aspects of its tariff agenda. But trading in Asia and Europe was mixed this morning.
Republican task force chief wants to shield Fed from political influence, including Trump
WASHINGTON (Reuters) -A Republican lawmaker tasked with scrutinizing Federal Reserve monetary policy wants the U.S. Congress to help stabilize financial markets by insulating the central bank from political influence, including from President Donald Trump. After days of market turmoil triggered by Trump's attacks on Fed Chairman Jerome Powell, Representative Frank Lucas said the president ultimately made the right call by stating clearly this week that he has no intention of firing the central bank chief.
Trump’s ‘art of the retreat’ may signal he’s setting Powell up to take the fall for economic turmoil
Trump’s tactical retreat on key points like Fed Chair Powell and trade negotiations with China signals a change within the White House—potentially lining up a scapegoat if its policies fall flat.
West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars
Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.